Cargando…
Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke
Stroke is a leading cause of morbidity and mortality worldwide, and consists of two types, ischemic and hemorrhagic. Currently, there is no effective treatment to increase the survival rate or improve the quality of life after ischemic and hemorrhagic stroke in the subacute to chronic phases. Theref...
Autores principales: | Kanazawa, Masato, Ninomiya, Itaru, Hatakeyama, Masahiro, Takahashi, Tetsuya, Shimohata, Takayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666817/ https://www.ncbi.nlm.nih.gov/pubmed/29027964 http://dx.doi.org/10.3390/ijms18102135 |
Ejemplares similares
-
A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivation
por: Hatakeyama, Masahiro, et al.
Publicado: (2019) -
Publisher Correction: A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivation
por: Hatakeyama, Masahiro, et al.
Publicado: (2019) -
Cell Therapies under Clinical Trials and Polarized Cell Therapies in Pre-Clinical Studies to Treat Ischemic Stroke and Neurological Diseases: A Literature Review
por: Hatakeyama, Masahiro, et al.
Publicado: (2020) -
Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke
por: Kanazawa, Masato, et al.
Publicado: (2017) -
Angiogenesis and neuronal remodeling after ischemic stroke
por: Hatakeyama, Masahiro, et al.
Publicado: (2019)